BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33627603)

  • 1. Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review.
    Olson SR; Murphree CR; Zonies D; Meyer AD; Mccarty OJT; Deloughery TG; Shatzel JJ
    ASAIO J; 2021 Mar; 67(3):290-296. PubMed ID: 33627603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
    Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
    Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO.
    Carter KT; Kutcher ME; Shake JG; Panos AL; Cochran RP; Creswell LL; Copeland H
    J Surg Res; 2019 Nov; 243():399-409. PubMed ID: 31277018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation.
    Dalton HJ; Reeder R; Garcia-Filion P; Holubkov R; Berg RA; Zuppa A; Moler FW; Shanley T; Pollack MM; Newth C; Berger J; Wessel D; Carcillo J; Bell M; Heidemann S; Meert KL; Harrison R; Doctor A; Tamburro RF; Dean JM; Jenkins T; Nicholson C;
    Am J Respir Crit Care Med; 2017 Sep; 196(6):762-771. PubMed ID: 28328243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.
    Mazzeffi MA; Tanaka K; Roberts A; Rector R; Menaker J; Kon Z; Deatrick KB; Kaczorowski D; Griffith B; Herr D
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1216-1220. PubMed ID: 30181084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding and Thrombotic Events During Extracorporeal Membrane Oxygenation for Postcardiotomy Shock.
    Melehy A; Ning Y; Kurlansky P; Kaku Y; Fried J; Hastie J; Ciolek A; Brodie D; Eisenberger AB; Sayer G; Uriel N; Takayama H; Naka Y; Takeda K
    Ann Thorac Surg; 2022 Jan; 113(1):131-137. PubMed ID: 33609547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation-Free Pediatric Extracorporeal Membrane Oxygenation: Single-Center Retrospective Study.
    Rabinowitz EJ; Danzo MT; Anderson MJ; Wallendorf M; Eghtesady P; Said AS
    Pediatr Crit Care Med; 2023 Jun; 24(6):499-509. PubMed ID: 36883843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
    Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
    Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review.
    Sanfilippo F; Currò JM; La Via L; Dezio V; Martucci G; Brancati S; Murabito P; Pappalardo F; Astuto M
    Artif Organs; 2022 Dec; 46(12):2371-2381. PubMed ID: 35531906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis.
    Nunez JI; Gosling AF; O'Gara B; Kennedy KF; Rycus P; Abrams D; Brodie D; Shaefi S; Garan AR; Grandin EW
    Intensive Care Med; 2022 Feb; 48(2):213-224. PubMed ID: 34921625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thombosis, major bleeding, and survival in COVID-19 supported by veno-venous extracorporeal membrane oxygenation in the first vs second wave: a multicenter observational study in the United Kingdom.
    Arachchillage DJ; Weatherill A; Rajakaruna I; Gaspar M; Odho Z; Isgro G; Cagova L; Fleming L; Ledot S; Laffan M; Szydlo R; Jooste R; Scott I; Vuylsteke A; Yusuff H
    J Thromb Haemost; 2023 Oct; 21(10):2735-2746. PubMed ID: 37423386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
    Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
    ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study.
    Mansour A; Flecher E; Schmidt M; Rozec B; Gouin-Thibault I; Esvan M; Fougerou C; Levy B; Porto A; Ross JT; Para M; Manganiello S; Lebreton G; Vincentelli A; Nesseler N;
    Intensive Care Med; 2022 Aug; 48(8):1039-1052. PubMed ID: 35829723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafamostat mesilate as a regional anticoagulant in patients with bleeding complications during extracorporeal membrane oxygenation.
    Park JH; Her C; Min HK; Kim DK; Park SH; Jang HJ
    Int J Artif Organs; 2015 Nov; 38(11):595-9. PubMed ID: 26728787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
    Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
    Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of safety and bleeding risk in the use of extracorporeal membrane oxygenation for multitrauma patients: A multicenter review.
    Kruit N; Prusak M; Miller M; Barrett N; Richardson C; Vuylsteke A
    J Trauma Acute Care Surg; 2019 Jun; 86(6):967-973. PubMed ID: 31124894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
    Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
    J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous or arterial thromboses after venoarterial extracorporeal membrane oxygenation support: Frequency and risk factors.
    Bidar F; Lancelot A; Lebreton G; Pineton de Chambrun M; Schmidt M; Hékimian G; Juvin C; Bréchot N; Schoell T; Leprince P; Combes A; Bouglé A; Luyt CE
    J Heart Lung Transplant; 2021 Apr; 40(4):307-315. PubMed ID: 33422407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation.
    Guo Z; Sun L; Li B; Tian R; Zhang X; Zhang Z; Clifford SP; Liu Y; Huang J; Li X
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):389-397. PubMed ID: 32994131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.